| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/2003 | US6503756 Antisense modulation of syntaxin 4 interacting protein expression |
| 01/07/2003 | US6503754 Antisense modulation of BH3 interacting domain death agonist expression |
| 01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
| 01/07/2003 | US6503732 An infectious modified Tobacco Mosaic Virus (TMV) virion comprising a coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous |
| 01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
| 01/07/2003 | US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503703 Identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. |
| 01/07/2003 | US6503543 Tryptophan source from plants and uses therefor |
| 01/07/2003 | US6503540 Cloning and characterization of bves, a novel gene expressed in heart and uses thereof |
| 01/07/2003 | US6503539 Matrix protein compositions for wound healing |
| 01/07/2003 | US6503534 Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/07/2003 | US6503533 Antisense ogligonucleotides against Hepatitis B viral replication |
| 01/07/2003 | US6503530 Method of preventing development of severe metabolic derangement in inborn errors of metabolism |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503512 Anti-AIDS immunomodulator complex |
| 01/07/2003 | US6503510 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 01/07/2003 | US6503508 Detergents |
| 01/07/2003 | US6503507 Oxygen activatable formulations for disinfection or sterilization |
| 01/07/2003 | US6503506 Nutrient therapy for immuno-compromised patients |
| 01/07/2003 | US6503504 In vitro cell growth to form tissue containing at least partially foreign DNA sequence which mediates production of the bioactive compound; implanting mass into an organism; treating diseases |
| 01/07/2003 | US6503502 Isolated DNA molecule encoding tumor suppressor inhibited pathway 2 consisting of nucleotide sequence ID 10; inhibiting tumor growth; inducing apoptosis |
| 01/07/2003 | US6503498 Apolipoprotein A-1 adenovirus vector compositions and methods |
| 01/07/2003 | US6503480 Aerodynamically light particles for pulmonary drug delivery |
| 01/07/2003 | US6503184 Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 |
| 01/07/2003 | CA2224792C Pharmaceutical preparation containing cyclosporin a |
| 01/07/2003 | CA2192481C Drug salts |
| 01/07/2003 | CA2149055C Antitumoral compositions containing taxan derivatives |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/06/2003 | CA2392288A1 Pharmaceutical preparation for the inhalation of antithrombin in anti-inflammatory lung diseases and ards |
| 01/05/2003 | CA2387981A1 Pharmaceutical composition |
| 01/03/2003 | WO2003001249A2 Modulating photoreactivity in a cell |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003001204A2 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | WO2003001198A1 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000918A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 01/03/2003 | WO2003000916A2 Telomerase expression repressor proteins and methods of using the same |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000901A2 Nucleic acids encoding protein kinases |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000894A1 Polynucleotide vaccine |
| 01/03/2003 | WO2003000891A2 Protein-protein interactions in the inner ear |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000865A2 Human secreted proteins |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000855A2 Chimeric capsid proteins and uses thereof |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000847A2 Membrane associated progesterone receptor |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000843A2 P53 binding protein-related protein in cardiomyopathy |
| 01/03/2003 | WO2003000777A2 Multi-arm block copolymers as drug delivery vehicles |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000734A2 Ion channel modulators |
| 01/03/2003 | WO2003000729A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000725A2 Regulation of human lipoate-protein ligase b-like enzyme |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000719A2 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000716A2 Preparation and use of amorphous lisinopril |
| 01/03/2003 | WO2003000707A2 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000633A2 A process for the isolation of a major harmful oxidant from cigarette smoke |
| 01/03/2003 | WO2003000293A1 Pharmaceutical formulation |
| 01/03/2003 | WO2003000287A1 Remedies for hernia |
| 01/03/2003 | WO2003000285A1 Tissue-specific transporter inhibitor |
| 01/03/2003 | WO2003000282A1 Sustained release formulation |
| 01/03/2003 | WO2003000281A1 Neuroprotection and/or neurorestoration via the neural avtivin type iib receptor |
| 01/03/2003 | WO2003000280A2 Abin-mediated hepatitis protection |
| 01/03/2003 | WO2003000279A1 GEMININ AND orc3N INHIBIT REPLICATION OF HERPESVIRUSES, PAPILLOMAVIRUSES, AND POLYOMAVIRUSES |
| 01/03/2003 | WO2003000278A1 Ointments |
| 01/03/2003 | WO2003000277A2 Antimicrobial peptides |
| 01/03/2003 | WO2003000235A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | WO2003000227A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | WO2003000209A1 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 01/03/2003 | WO2003000203A2 Chlorotoxin inhibition of cell invasion, cancer metastasis, angiogenesis and tissue remodeling |
| 01/03/2003 | WO2003000202A2 Particles for inhalation having rapid release properties |
| 01/03/2003 | WO2003000199A2 Ilt3 and ilt4-related compositions and methods |
| 01/03/2003 | WO2003000198A2 Selective neuronal nitric oxide synthase inhibitors |
| 01/03/2003 | WO2003000196A2 Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof |
| 01/03/2003 | WO2003000193A2 Covalent coupling of botulinum toxin with polyethylene glycol |
| 01/03/2003 | WO2003000179A2 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | WO2003000178A2 Black soybean polysaccharides |
| 01/03/2003 | WO2003000173A2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 01/03/2003 | WO2003000158A1 Pharmaceutical composition |
| 01/03/2003 | WO2003000156A1 Zero-order prolonged release coaxial implants |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2003000111A2 Human ugrp (uteroglobin-related protein) 1 promoter and its use |
| 01/03/2003 | WO2003000046A1 Cyt28 serpentine receptor disruptions, compositions and methods relating thereto |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |